Literature DB >> 28818856

Deletion of NF-κB/RelA in Angiotensin II-Sensitive Mesenchymal Cells Blocks Aortic Vascular Inflammation and Abdominal Aortic Aneurysm Formation.

Talha Ijaz1, Hong Sun1, Irina V Pinchuk1, Dianna M Milewicz1, Ronald G Tilton1, Allan R Brasier2.   

Abstract

OBJECTIVE: Infusion of angiotensin II (Ang II) induces extracellular matrix remodeling and inflammation resulting in abdominal aortic aneurysms (AAAs) in normolipidemic mice. Although Ang II activates mesenchymal cells in the media and adventitia to become fibrogenic, the sentinel role of this mesenchymal population in modulating the inflammatory response and aneurysms is not known. We test the hypothesis that these fibrogenic mesenchymal cells play a critical role in Ang II-induced aortic wall vascular inflammation and AAA formation. APPROACH AND
RESULTS: Ang II infusion increased phospho-Ser536-RelA and interleukin (IL)-6 immunostaining in the abdominal aorta. In addition, aortic mRNA transcripts of RelA-dependent cytokines IL-6 and IL-1β were significantly elevated suggesting that Ang II functionally activates RelA signaling. To test the role of mesenchymal RelA in AAA formation, we generated RelA-CKO mice by administering tamoxifen to double transgenic mice harboring RelA-flox alleles and tamoxifen-inducible Col1a2 promoter-driven Cre recombinase (Col1a2-CreERT). Tamoxifen administration to Col1a2-CreERT•mT/mG mice induced Cre expression and RelA depletion in aortic smooth muscle cells and fibroblasts but not in endothelial cells. Infusion of Ang II significantly increased abdominal aortic diameter and the incidence of AAA in RelA wild-type but not in RelA-CKO mice, independent of changes in systolic blood pressure. Furthermore, mesenchymal cell-specific RelA-CKO mice exhibited decreased expression of IL-6 and IL-1β cytokines and decreased recruitment of C68+ and F4/80lo•Ly6Chi monocytes during Ang II infusion.
CONCLUSIONS: Fibrogenic mesenchymal RelA plays a causal role in Ang II-induced vascular inflammation and AAA in normolipidemic mice.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; animals; aortic aneurysm, abdominal; blood pressure; interleukin-6

Mesh:

Substances:

Year:  2017        PMID: 28818856      PMCID: PMC5620126          DOI: 10.1161/ATVBAHA.117.309863

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  49 in total

1.  Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.

Authors:  N Fukuda; W Y Hu; A Kubo; H Kishioka; C Satoh; M Soma; Y Izumi; K Kanmatsuse
Journal:  Am J Hypertens       Date:  2000-02       Impact factor: 2.689

2.  Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling.

Authors:  Brian C Tieu; Xiaoxi Ju; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Allan R Brasier; Ronald G Tilton
Journal:  J Vasc Res       Date:  2010-11-23       Impact factor: 1.934

3.  Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.

Authors:  Biao Hu; Zhe Wu; Taku Nakashima; Sem H Phan
Journal:  Am J Pathol       Date:  2012-04-11       Impact factor: 4.307

4.  Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.

Authors:  Fumitake Usui; Koumei Shirasuna; Hiroaki Kimura; Kazuki Tatsumi; Akira Kawashima; Tadayoshi Karasawa; Koichi Yoshimura; Hiroki Aoki; Hiroko Tsutsui; Tetsuo Noda; Junji Sagara; Shun'ichiro Taniguchi; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

5.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

7.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.

Authors:  Nathaniel M Weathington; Anneke H van Houwelingen; Brett D Noerager; Patricia L Jackson; Aletta D Kraneveld; F Shawn Galin; Gert Folkerts; Frans P Nijkamp; J Edwin Blalock
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440

8.  Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B.

Authors:  M Bond; R P Fabunmi; A H Baker; A C Newby
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

9.  Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.

Authors:  Alan Daugherty; Debra L Rateri; Israel F Charo; A Phillip Owens; Deborah A Howatt; Lisa A Cassis
Journal:  Clin Sci (Lond)       Date:  2010-03-09       Impact factor: 6.124

Review 10.  Extracellular matrix synthesis in vascular disease: hypertension, and atherosclerosis.

Authors:  Markella Ponticos; Barbara D Smith
Journal:  J Biomed Res       Date:  2013-09-20
View more
  18 in total

Review 1.  Vascular Development.

Authors:  Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03       Impact factor: 8.311

Review 2.  Updates of Recent Aortic Aneurysm Research.

Authors:  Frank M Davis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

Review 3.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Expression of immunomodulatory and tissue regenerative biomarkers in human dental pulp derived-mesenchymal stem cells treated with curcumin: an in vitro study.

Authors:  Malaksima Ayadilord; Mansoore Saharkhiz; Mohsen Naseri; Fariba Emadian Razavi
Journal:  Mol Biol Rep       Date:  2022-03-17       Impact factor: 2.742

5.  Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.

Authors:  Aaron C Petrey; Fares Qeadan; Elizabeth A Middleton; Irina V Pinchuk; Robert A Campbell; Ellen J Beswick
Journal:  J Leukoc Biol       Date:  2020-09-15       Impact factor: 4.962

6.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

7.  Inducible Depletion of Calpain-2 Mitigates Abdominal Aortic Aneurysm in Mice.

Authors:  Latha Muniappan; Michihiro Okuyama; Aida Javidan; Devi Thiagarajan; Weihua Jiang; Jessica J Moorleghen; Lihua Yang; Anju Balakrishnan; Deborah A Howatt; Haruhito A Uchida; Takaomi C Saido; Venkateswaran Subramanian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-25       Impact factor: 8.311

Review 8.  Twenty Years of Studying AngII (Angiotensin II)-Induced Abdominal Aortic Pathologies in Mice: Continuing Questions and Challenges to Provide Insight Into the Human Disease.

Authors:  Hisashi Sawada (澤田悠); Hong S Lu (吕红); Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-01-20       Impact factor: 8.311

9.  Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2.

Authors:  Haoyu Song; Tong Xu; Xiaofei Feng; Yanxian Lai; Yang Yang; Hao Zheng; Xiang He; Guoquan Wei; Wangjun Liao; Yulin Liao; Lintao Zhong; Jianping Bin
Journal:  EBioMedicine       Date:  2020-06-20       Impact factor: 8.143

Review 10.  Impact of miRNA in Atherosclerosis.

Authors:  Yao Lu; Tanuja Thavarajah; Wenduo Gu; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.